Stevens L M, Yamamoto T, Davis P L. "Method for the Synthesis of 2-(5-Chlorochroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane" [P]. US Patent, US 10772173 B2, 2016-06-11.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2015, 2071, 621-638.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2021, 2110, (12), 6748-6753.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 2-(5-Chlorochroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Using HRMS and NMR". Sci. Total Environ., 2015, 1148, (4), 4124-4130.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2019, 490, (9), 2556-2567.